(Q30321299)

17 June 2017

title

Aspirin protects endothelial cells from oxidative stress--possible synergism with vitamin E. (English)

1 reference

17 June 2017

0 references

1 reference

Podhaisky HP

1

1 reference

17 June 2017

Abate A

2

1 reference

17 June 2017

Polte T

3

1 reference

17 June 2017

Oberle S

4

1 reference

17 June 2017

Schröder H

5

1 reference

17 June 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

17 June 2017

1 reference

17 June 2017

volume

417

1 reference

17 June 2017

issue

3

1 reference

17 June 2017

page(s)

349-351

1 reference

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Aspirin in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Nitric oxide protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible involvement of cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

The case of low-dose aspirin for the prevention of myocardial infarction: but how low is low?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Activation of protein phosphorylation by oxidants in vascular endothelial cells: identification of tyrosine phosphorylation of caveolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Antioxidant defense mechanisms of endothelial cells: glutathione redox cycle versus catalase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Hydrogen peroxide alters the physical state and function of the plasma membrane of pulmonary artery endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901307-0

10.1016/S0014-5793(97)01307-0

7 January 2021

Identifiers

DOI

1 reference

17 June 2017

1 reference